2023 Annual Report
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
2023 Annual Report
Filed with SSE ·
2023 Annual Report
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
6ix hasn’t read this filing yet.
Jianmin Pharmaceutical Group Co Ltd. on 6ix
Later from Jianmin Pharmaceutical
- Announcement on Resolutions of 2023 Annual General Meeting
- Announcement on Marketing Approval of Terbutaline Sulfate Nebuliser Solution
- Announcement on Implementation of Dividend Distribution of 2023
- Announcement on Attending Online Collective Reception Day for Investors of Listed Companies in Hubei Jurisdiction in 2024
- Announcement on Implementation of Providing Guarantees for Subsidiaries' Bank Credit Lines
Follow Jianmin Pharmaceutical into a list and get an email when it puts out news.
Follow Jianmin Pharmaceutical